tadalafil NDC 71335-2467

Product information

Brand name (proprietary)

tadalafil

Generic name (nonproprietary)

tadalafil

Active ingredients

Tadalafil — 5 mg/1

Dosage form

Tablet, Film coated

Route

Oral

Labeler

Bryant Ranch Prepack

Product type

Prescription drug

Marketing category

ANDA — Abbreviated New Drug Application (generic)Application ANDA 209250

Marketing start

Mar 26, 2019

Listing expires

Dec 31, 2026

Other FDA classes

Phosphodiesterase 5 Inhibitors (Mechanism)

Identifiers

Product ID 71335-2467_f79b51c1-60c1-4a52-939e-81ee8f2148aeSPL ID f79b51c1-60c1-4a52-939e-81ee8f2148aeSPL set ID ff3c7dd3-2dcc-498c-a121-1e2aa62c7a97RxCUI 403957UNII 742SXX0ICT

Pharmacologic class

Phosphodiesterase 5 Inhibitor

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N471335246701 followed by a unit qualifier and the quantity Copy

Package 71335-2467-01. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Other NDCs under ANDA 209250

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.